Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • gwilson
    Junior Member
    • Dec 2009
    • 5

    Understanding the qmap bis-seq format

    Hello,

    I hoping somebody can help me to understand the qmap format, used to describe the bis-seq methylome data from recent papers. I downloaded the data from GEO (GSE17972). It would be great if you could you take a look at the questions below, or alternatively if you know of the software that generates qmap files, I could see if there is further explanation in the manual. I’ve read the format description (attached) from the GEO entry but this hasn’t answered all my questions. I’ve pasted an example line below to help illustrate my problems.

    1. Columns 6-10 are involved with tags that map repeatedly. Does this mean that these tags have mapped to many different locations on the reference genome with the same mapping quality?
    2. I don’t understand the difference between column 3 and column 4. How do some tags (in this example, 4 tags) provide no information regarding methylation? The bisulphite converted read would presumably show the base as being C (methylated) or T (unmethylated) and would therefore be counted in column 2 or 3. What goes in column 4?
    3. Column 10 shows the sum of tags mapped repeatedly to the reference at this site. I took this to mean columns 6 + 7 + 8 + 9. However, in the example below that would equal 0+1+3+0=4, not the given value of 9896. Clearly I’m missing something!


    C 0 9 4 1 0 1 3 0 9896 550.56 Wh_V^hYUh


    Many Thanks,

    Gareth
    Attached Files
  • freefly
    Junior Member
    • Jul 2011
    • 2

    #2
    I think column10 is the total hits of reads mapped across this site on the whole genome

    Comment

    • sciencewu
      Member
      • Dec 2010
      • 12

      #3
      1. you are right,but I am not sure all the mapping locations with the same mapping quality.
      2. The column 3 give you the mapping hits which can't not give you the methylation information
      3.The column 10 is the total hits of ambiguous mapped reads across this site on the whole genome scale.

      Comment

      • Tlexander
        Member
        • Aug 2010
        • 14

        #4
        Any idea to transfer qmap to bigwig/bedgraph/wig to show the methylation level for each postion?

        Comment

        Latest Articles

        Collapse

        • mylaser
          Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by mylaser
          Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
          If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
          This guide explains everything you need to know about...
          Today, 01:13 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        16 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-08-2026, 10:08 AM
        0 responses
        10 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-07-2026, 11:05 AM
        0 responses
        22 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-02-2026, 11:08 AM
        0 responses
        31 views
        0 reactions
        Last Post SEQadmin2  
        Working...